Host Modulators of H1N1 Cytopathogenicity

Influenza A virus infects 5–20% of the population annually, resulting in ∼35,000 deaths and significant morbidity. Current treatments include vaccines and drugs that target viral proteins. However, both of these approaches have limitations, as vaccines require yearly development and the rapid evolut...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Samuel E., Kim, Hyun Seok, Komurov, Kakajan, Mendiratta, Saurabh, Tsai, Pei-Ling, Schmolke, Mirco, Satterly, Neal, Manicassamy, Balaji, Forst, Christian V., Roth, Michael G., García-Sastre, Adolfo, Blazewska, Katarzyna M., McKenna, Charles E., Fontoura, Beatriz M., White, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410888/
https://www.ncbi.nlm.nih.gov/pubmed/22876275
http://dx.doi.org/10.1371/journal.pone.0039284

Ejemplares similares

Ejemplares similares